Drugs in R & D

, Volume 7, Issue 4, pp 203–217 | Cite as

The Potential of Plant Virus Vectors for Vaccine Production

  • Vidadi Yusibov
  • Shailaja Rabindran
  • Ulrich Commandeur
  • Richard M. Twyman
  • Rainer Fischer
Review Article


Plants viruses are versatile vectors that allow the rapid and convenient production of recombinant proteins in plants. Compared with production systems based on transgenic plants, viral vectors are easier to manipulate and recombinant proteins can be produced more quickly and in greater yields. Over the last few years, there has been much interest in the development of plant viruses as vectors for the production of vaccines, either as whole polypeptides or epitopes displayed on the surface of chimeric viral particles. Several viruses have been extensively developed for vaccine production, including tobacco mosaic virus, potato virus X and cowpea mosaic virus. Vaccine candidates have been produced against a range of human and animal diseases, and in many cases have shown immunogenic activity and protection in the face of disease challenge. In this review, we discuss the advantages of plant virus vectors, the development of different viruses as vector systems, and the immunological experiments that have demonstrated the principle of plant virus-derived vaccines.


Coat Protein Tobacco Mosaic Virus Cucumber Mosaic Virus Coat Protein Gene Zucchini Yellow Mosaic Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No funding was received to assist in the preparation of this review, and the authors have no conflicting financial interests.


  1. 1.
    Twyman RM, Schillberg S, Fischer R. Transgenic plants in the biopharmaceutical market. Expert Opin Emerg Drugs 2005; 10: 185–218PubMedCrossRefGoogle Scholar
  2. 2.
    Ma JKC, Drake P, Christou P. The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 2003; 4: 794–805PubMedCrossRefGoogle Scholar
  3. 3.
    Ma JKC, Barros E, Bock R, et al. Molecular farming for new drugs and vaccines: current perspectives on the production of pharmaceuticals in transgenic plants. EMBO Rep 2005; 6: 593–9PubMedCrossRefGoogle Scholar
  4. 4.
    Ma JKC, Chikwamba R, Dale PJ, et al. Plant-derived pharmaceuticals: the road forward. Trends Plant Sci 2005; 10: 580–5PubMedCrossRefGoogle Scholar
  5. 5.
    Dow AgroSciences achieves world’s first registration for plant-made vaccines [online]. Available from URL: [Accessed 2006 May 5]
  6. 6.
    Twyman RM, Stoger E, Schillberg S, et al. Molecular farming in plants: host systems and expression technology. Trends Biotechnol 2003; 21: 570–8PubMedCrossRefGoogle Scholar
  7. 7.
    Fischer R, Stoger E, Schillberg S, et al. Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 2004; 7: 152–8PubMedCrossRefGoogle Scholar
  8. 8.
    Kapila J, Derycke R, van Montagu M, et al. An Agrobacterium-mediated transient gene expression system for intact leaves. Plant Sci 1997; 122: 101–8CrossRefGoogle Scholar
  9. 9.
    Hellwig S, Drossard J, Twyman RM, et al. Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 2004; 22: 1415–22PubMedCrossRefGoogle Scholar
  10. 10.
    Awram P, Gardner RC, Forster RL, et al. The potential of plant viral vectors and transgenic plants for subunit vaccine production. Adv Virus Res 2002; 58: 81–124PubMedCrossRefGoogle Scholar
  11. 11.
    Pogue GP, Lindbo JA, Garger SJ, et al. Making an ally from an enemy: plant virology and the new agriculture. Annu Rev Phytopathol 2002; 40: 45–74PubMedCrossRefGoogle Scholar
  12. 12.
    Scholthof KB, Mirkov TE, Scholthof HB. Plant virus gene vectors: biotechnology applications in agriculture and medicine. Genet Eng 2002; 24: 67–85CrossRefGoogle Scholar
  13. 13.
    Porta C, Lomonossoff GP. Viruses as vectors for the expression of foreign sequences in plants. Biotechnol Genet Eng Rev 2002; 19: 245–91PubMedGoogle Scholar
  14. 14.
    Porta C, Lomonossoff GP. Scope for using plant viruses to present epitopes from animal pathogens. Rev Med Virol 1998; 8: 25–41PubMedCrossRefGoogle Scholar
  15. 15.
    Lomonossoff GP, Johnson JE. Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines. Curr Opin Struct Biol 1996; 6: 176–82PubMedCrossRefGoogle Scholar
  16. 16.
    Wigdorovitz A, Perez Filgueira DM, Robertson N, et al. Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expres-sing the FMDV structural protein VP1. Virology 1999; 264: 85–91PubMedCrossRefGoogle Scholar
  17. 17.
    McCormick AA, Kumagai MH, Hanley K, et al. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc Natl Acad Sci U S A 1999; 96: 703–8PubMedCrossRefGoogle Scholar
  18. 18.
    McCormick AA, Reinl SJ, Cameron TI, et al. Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. J Immunol Methods 2003; 278: 95–104PubMedCrossRefGoogle Scholar
  19. 19.
    Krebitz M, Wiedermann U, Essl D, et al. Rapid production of the major birch pollen allergen Betv 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterization. FASEB J 2000; 14: 1279–88PubMedCrossRefGoogle Scholar
  20. 20.
    Perez Filgueira DM, Mozgovoj M, Wigdorovitz A, et al. Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8* produced in plants using a TMV-based vector. Arch Virol 2004; 149: 2337–48PubMedCrossRefGoogle Scholar
  21. 21.
    Nemchinov LG, Liang TJ, Rifaat MM, et al. Development of a plant-derived subunit vaccine candidate against hepatitis C virus. Arch Virol 2000; 145: 2557–73PubMedCrossRefGoogle Scholar
  22. 22.
    Koo M, Bendahmane M, Lettieri GA, et al. Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope. Proc Natl Acad Sci U S A 1999; 96: 7774–9PubMedCrossRefGoogle Scholar
  23. 23.
    Fitchen J, Beachy RN, Hein MB. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine 1995; 13: 1051–7PubMedCrossRefGoogle Scholar
  24. 24.
    Wu L, Jiang L, Zhou Z, et al. Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector. Vaccine 2003; 21: 4390–8PubMedCrossRefGoogle Scholar
  25. 25.
    Staczek J, Bendahmane M, Gilleland LB, et al. Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. Aeruginosa. Vaccine 2000; 18: 2266–74PubMedCrossRefGoogle Scholar
  26. 26.
    Gilleland HE, Gilleland LB, Staczek J, et al. Chimeric animal and plant viruses expressing epitopes of outer membrane pro-tein F as a combined vaccine against Pseudomonas aeruginosa lung infection. FEMS Immunol Med Microbiol 2000; 27: 291–7PubMedCrossRefGoogle Scholar
  27. 27.
    Kang TJ, Kang KH, Kim JA, et al. High-level expression of the neutralizing epitope of porcine epidemic diarrhea virus by a tobacco mosaic virus-based vector. Protein Expr Purif 2004; 38: 129–35PubMedCrossRefGoogle Scholar
  28. 28.
    Yusibov V, Modelska A, Steplewski K, et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci U S A 1997; 94: 5784–8PubMedCrossRefGoogle Scholar
  29. 29.
    Modelska A, Dietzschold B, Fleysh N, et al. Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci U S A 1998; 95: 2481–5PubMedCrossRefGoogle Scholar
  30. 30.
    Yusibov V, Hooper DC, Spitsin SV, et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002; 20: 3155–64PubMedCrossRefGoogle Scholar
  31. 31.
    Santi L, Giritch A, Roy CJ, et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci U S A 2006; 103: 861–6PubMedCrossRefGoogle Scholar
  32. 32.
    Smith ML, Lindbo JA, Dillard-Telm S, et al. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology. Epub 2006 Feb 6Google Scholar
  33. 33.
    Franconi R, Di Bonito P, Dibello F, et al. Plant derived-human papillomavirus 16 E7 oncoprotein induces immune response and specific tumour protection. Cancer Res 2002; 62: 3654–8PubMedGoogle Scholar
  34. 34.
    O’Brien GJ, Bryant CJ, Voogd C, et al. Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into virus like particles. Virology 2000; 270: 444–53PubMedCrossRefGoogle Scholar
  35. 35.
    Clemente M, Curilovic R, Sassone A, et al. Production of the main surface antigen of Toxoplasma gondii in tobacco leaves and analysis of its antigenicity and immunogenicity. Mol Biotechnol 2005; 30: 41–50PubMedCrossRefGoogle Scholar
  36. 36.
    Marusic C, Rizza P, Lattanzi L, et al. Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol 2001; 75: 8434–9PubMedCrossRefGoogle Scholar
  37. 37.
    Brennan FR, Jones TD, Longstaff M, et al. Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 1999; 17: 1846–57PubMedCrossRefGoogle Scholar
  38. 38.
    Canizares MC, Lomonossoff GP, Nicholson L. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants. Expert Rev Vaccines 2005; 4: 687–97PubMedCrossRefGoogle Scholar
  39. 39.
    Langeveld JP, Brennan FR, Martinez-Torrecuadrada JL, et al. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parovovirus. Vaccine 2001; 19: 3661–70PubMedCrossRefGoogle Scholar
  40. 40.
    Nicholas BL, Brennan FR, Martinez-Torrecuadrada JL, et al. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. Vaccine 2002; 20: 2727–34PubMedCrossRefGoogle Scholar
  41. 41.
    Usha R, Rohll JB, Spall VE, et al. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology 1993; 197: 366–74PubMedCrossRefGoogle Scholar
  42. 42.
    Dalsgaard K, Uttenthal A, Jones TD, et al. Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol 1997; 15: 248–52PubMedCrossRefGoogle Scholar
  43. 43.
    Porta C, Spall VE, Loveland J, et al. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology 1994; 202: 949–55PubMedCrossRefGoogle Scholar
  44. 44.
    Brennan FR, Gilleland LB, Staczek J, et al. A chimaeric plant virus vaccine protects mice against a bacterial infection. Microbiology 1999; 145: 2061–7PubMedCrossRefGoogle Scholar
  45. 45.
    Brennan FR, Jones TD, Gilleland LB, et al. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology 1999; 145: 211–20PubMedCrossRefGoogle Scholar
  46. 46.
    McLain L, Durrani Z, Wisniewski LA, et al. Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus. Vaccine 1996; 14: 799–810PubMedCrossRefGoogle Scholar
  47. 47.
    McLain L, Porta C, Lomonossoff GP, et al. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retroviruses 1995; 11: 327–34PubMedCrossRefGoogle Scholar
  48. 48.
    Yasawardene SG, Lomonossoff GP, Ramasamy R. Expression and immunogenicity of malaria merozoite peptides displayed on the small coat protein of chimaeric cowpea mosaic virus. Indian J Med Res 2003; 118: 115–24PubMedGoogle Scholar
  49. 49.
    Fernandez-Fernandez MR, Mourino M, Rivera J, et al. Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector. Virology 2001; 280: 283–91Google Scholar
  50. 50.
    Fernandez-Fernandez MR, Martinez-Torrecuadrada JL, Casal JI, et al. Development of an antigen presentation system based on plum pox potyvirus. FEBS Lett 1998; 427: 229–35PubMedCrossRefGoogle Scholar
  51. 51.
    Belanger H, Fleysh N, Cox S, et al. Human respiratory syncytial virus vaccine antigen produced in plants. FASEB J 2000; 14: 2323–8PubMedCrossRefGoogle Scholar
  52. 52.
    Yusibov V, Mett V, Mett V, et al. Peptide-based candidate vaccine against respiratory syncytial virus. Vaccine 2005; 23: 2261–5PubMedCrossRefGoogle Scholar
  53. 53.
    Joelson T, Akerblom L, Oxelfelt P, et al. Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol 1997; 78: 1213–7PubMedGoogle Scholar
  54. 54.
    Zhang GC, Leung C, Murdin L, et al. In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector. Mol Biotechnol 2000; 14: 99–107PubMedCrossRefGoogle Scholar
  55. 55.
    Natilla A, Piazzolla G, Nuzzaci M, et al. Cucumber mosaic virus as carrier of a hepatitis C virus-derived epitope. Arch Virol 2004; 149: 137–54PubMedCrossRefGoogle Scholar
  56. 56.
    Piazzolla G, Nuzzaci M, Tortorella C, et al. Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. J Clin Immunol 2005; 25: 142–52PubMedCrossRefGoogle Scholar
  57. 57.
    Kumagai MH, Turpen TH, Weinzettl N, et al. Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector. Proc Natl Acad Sci U S A 1993; 90: 427–30PubMedCrossRefGoogle Scholar
  58. 58.
    Donson J, Kearney CM, Hilf ME, et al. Systemic expression of a bacterial gene by a tobacco mosaic virus-based vector. Proc Natl Acad Sci U S A 1991; 88: 7204–8PubMedCrossRefGoogle Scholar
  59. 59.
    Shivprasad S, Pogue GP, Lewandowski DJ, et al. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors. Virology 1999; 255: 312–23PubMedCrossRefGoogle Scholar
  60. 60.
    Canizares MC, Nicholson L, Lomonossoff GP. Use of viral vectors for vaccine production in plants. Immunol Cell Biol 2005; 83: 263–70PubMedCrossRefGoogle Scholar
  61. 61.
    Verch T, Yusibov V, Koprowski H. Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector. J Immunol Methods 1998; 220: 69–75PubMedCrossRefGoogle Scholar
  62. 62.
    Perez-Filgueira DM, Zamorano PI, Dominguez MG, et al. Bovine herpes virus gD protein produced in plants using a recom-binant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 2003; 21: 4201–9PubMedCrossRefGoogle Scholar
  63. 63.
    Hamamoto H, Sugiyama Y, Nakagawa N, et al. A new tobacco mosaic virus vector and its use for the systemic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomato. Biotechnology (N Y) 1993; 11: 930–2CrossRefGoogle Scholar
  64. 64.
    Turpen TH, Reinl SJ, Charoenvit Y, et al. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Biotechnology (N Y) 1995; 13: 53–7CrossRefGoogle Scholar
  65. 65.
    Bendahmane M, Koo M, Karrer E, et al. Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions. J Mol Biol 1990; 290: 9–20CrossRefGoogle Scholar
  66. 66.
    Dalmay T, Hamilton A, Mueller E, et al. Potato virus X amplicons in Arabidopsis mediate genetic and epigenetic gene silencing. Plant Cell 2000; 12: 369–79PubMedGoogle Scholar
  67. 67.
    Santa Cruz S, Chapman S, Roberts AG, et al. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci U S A 1996; 93: 6286–90CrossRefGoogle Scholar
  68. 68.
    Donnelly ML, Luke G, Mehrotra A, et al. Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’. J Gen Virol 2000; 82: 1013–25Google Scholar
  69. 69.
    Toth RL, Chapman S, Carr F, et al. A novel strategy for the expression of foreign genes from plant virus vectors. FEBS Lett 2001; 489: 215–9PubMedCrossRefGoogle Scholar
  70. 70.
    Uhde K, Fischer R, Commandeur U. Expression of multiple foreign epitopes presented as synthetic antigens on the surface of potato virus X particles. Arch Virol 2005; 150: 327–40PubMedCrossRefGoogle Scholar
  71. 71.
    Porta C, Spall VE, Findlay KC, et al. Cowpea mosaic virus-based chimaeras: effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology 2003; 310: 50–63PubMedCrossRefGoogle Scholar
  72. 72.
    Lomonossoff GP, Hamilton WD. Cowpea mosaic virus-based vaccines. Curr Top Microbiol Immunol 1999; 240: 177–89PubMedGoogle Scholar
  73. 73.
    Verver J, Wellink J, Van Lent J, et al. Studies on the movement of cowpea mosaic virus using the jellyfish green fluorescent protein. Virology 1998; 242: 22–7PubMedCrossRefGoogle Scholar
  74. 74.
    Gopinath K, Wellink J, Porta C, et al. Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants. Virology 2000; 267: 159–73PubMedCrossRefGoogle Scholar
  75. 75.
    Lopez-Moya JJ, Fernandez-Fernandez MR, Cambra M, et al. Biotechnological aspects of plum pox virus. J Biotechnol 2000; 76: 121–36PubMedCrossRefGoogle Scholar
  76. 76.
    Fernandez-Fernandez MR, Martinez-Torrecuadrada JL, Roncal F, et al. Identification of immunogenic hot spots within plum pox potyvirus capsid protein for efficient antigen presentation. J Virol 2002; 76: 12646–53PubMedCrossRefGoogle Scholar
  77. 77.
    Sanchez-Navarro J, Miglino R, Ragozzino A, et al. Engineering of alfalfa mosaic virus RNA 3 into an expression vector. Arch Virol 2001; 146: 923–39PubMedCrossRefGoogle Scholar
  78. 78.
    Scholthof HB. Rapid delivery of foreign genes into plants by direct rub-inoculation with intact plasmid DNA of a tomato bushy stunt virus gene vector. J Virol 1999; 73: 7823–9PubMedGoogle Scholar
  79. 79.
    Arazi T, Lee Huang P, Huang PL, et al. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII. Biochem Biophys Res Commun 2002; 292: 441–8PubMedCrossRefGoogle Scholar
  80. 80.
    Savelyeva N, Munday R, Spellerberg MB, et al. Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies. Nat Biotechnol 2001; 19: 760–4PubMedCrossRefGoogle Scholar
  81. 81.
    Brennan FR, Jones TD, Hamilton WD. Cowpea mosaic virus as a vaccine carrier of heterologous antigens. Mol Biotechnol 2001; 17: 15–26PubMedCrossRefGoogle Scholar
  82. 82.
    Toth RL, Pogue GP, Chapman S. Improvement of the movement and host range properties of a plant virus vector through DNA shuffling. Plant J 2002; 30: 593–600PubMedCrossRefGoogle Scholar
  83. 83.
    Spitsin S, Steplewski K, Fleysh N, et al. Expression of alfalfa mosaic virus coat protein in tobacco mosaic virus (TMV) deficient in the production of its native coat protein supports long-distance movement of a chimeric TMV. Proc Natl Acad Sci U S A 1999; 96: 2549–53PubMedCrossRefGoogle Scholar
  84. 84.
    Holt CA, Beachy RN. In vivo complementation of infectious transcripts from mutant tobacco mosaic virus cDNAs in transgenic plants. Virology 1991; 181: 109–17PubMedCrossRefGoogle Scholar
  85. 85.
    Sanz AI, Serra MT, Garcia-Luque I. Altered local and systemic spread of movement deficient virus in transgenic tobacco plants expressing the cucumber mosaic virus 3a protein. Arch Virol 2000; 145: 2387–401PubMedCrossRefGoogle Scholar
  86. 86.
    Marillonnet S, Giritch A, Gils M, et al. In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc Natl Acad Sci U S A 2004; 101: 6852–7PubMedCrossRefGoogle Scholar
  87. 87.
    Marillonnet S, Thoeringer C, Kandzia R, et al. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nat Biotechnol 2005; 23: 718–23PubMedCrossRefGoogle Scholar
  88. 88.
    Gleba Y, Klimyuk V, Marillonnet S. Magnifection: a new platform for expressing recombinant vaccines in plants. Vaccine 2005; 23: 2042–8PubMedCrossRefGoogle Scholar
  89. 89.
    Gleba Y, Marillonnet S, Klimyuk V. Engineering viral expression vectors for plants: the ‘full virus’ and the ‘deconstructed virus’ strategies. Curr Opin Plant Biol 2004; 7: 182–8PubMedCrossRefGoogle Scholar
  90. 90.
    Choi IR, Stenger DC, Morris TJ, et al. A plant virus vector for systemic expression of foreign genes in cereals. Plant J 2000; 23: 547–55PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  • Vidadi Yusibov
    • 1
  • Shailaja Rabindran
    • 1
  • Ulrich Commandeur
    • 2
  • Richard M. Twyman
    • 3
  • Rainer Fischer
    • 2
    • 4
  1. 1.Fraunhofer USA Center for Molecular BiotechnologyNewarkUSA
  2. 2.Institute for Molecular Biotechnology, Biology VIIRWTH AachenAachenGermany
  3. 3.Department of BiologyUniversity of YorkHeslington, YorkUK
  4. 4.Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)AachenGermany

Personalised recommendations